Justin Smith
Stock Analyst at Bernstein
(4.17)
# 1,734
Out of 4,662 analysts
179
Total ratings
61.3%
Success rate
9.8%
Average return
Main Sectors:
Stocks Rated by Justin Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: MRK Merck KGaA | Maintained: Hold | €112.00 → €151.00 | €138.35 | +9.14% | 2 | Aug 7, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Sell | kr 175.00 → kr 200.00 | kr 292.75 | -31.68% | 3 | Aug 5, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €107.00 → €106.21 | €78.56 | +35.20% | 4 | Aug 4, 2026 | |
| LON: GSK GSK plc | Maintained: Buy | 2,825p → 3,010p | 1,916p | +57.10% | 25 | Aug 3, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | 18,900p → 20,200p | 12,050p | +67.63% | 34 | Jul 29, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | €877.00 → €986.00 | €881.20 | +11.89% | 13 | Jul 28, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Buy | CHF 395.00 → CHF 434.50 | CHF 367.40 | +18.26% | 26 | Jul 27, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | n/a | $579.20 | - | 9 | Jul 24, 2026 | |
| SWX: NOVN Novartis AG | Rated: Hold | CHF 125.00 → CHF 133.00 | CHF 127.12 | +4.63% | 2 | Jul 22, 2026 | |
| NVS Novartis AG | Initiated Coverage: Hold | n/a | $160.31 | - | 1 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | kr 1,015 → kr 1,400 | kr 2,152 | -34.94% | 9 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $34.11 | - | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $28.24 | n/a | 8 | Aug 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €10.50 → €2.90 | €0.98 | n/a | 3 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €22.00 → €21.50 | €10.08 | n/a | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $85 → $51 | $67.61 | n/a | 10 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $104 | $152.20 | n/a | 4 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €45.80 → €71.00 | €40.93 | n/a | 7 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €69.00 → €70.00 | €46.65 | n/a | 6 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $58.20 | n/a | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $172 → $140 | $265.97 | n/a | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $52.88 | n/a | 1 | Sep 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.69 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $23.84 | n/a | 1 | Feb 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $78 | $1,280.34 | n/a | 1 | Apr 7, 2016 |
Merck KGaA
Aug 7, 2026
Maintained: Hold
Price Target: €112.00 → €151.00
Current: €138.35
Upside: +9.14%
Novo Nordisk A/S
Aug 5, 2026
Maintained: Sell
Price Target: kr 175.00 → kr 200.00
Current: kr 292.75
Upside: -31.68%
Sanofi
Aug 4, 2026
Maintained: Buy
Price Target: €107.00 → €106.21
Current: €78.56
Upside: +35.20%
GSK plc
Aug 3, 2026
Maintained: Buy
Price Target: 2,825p → 3,010p
Current: 1,916p
Upside: +57.10%
AstraZeneca PLC
Jul 29, 2026
Maintained: Buy
Price Target: 18,900p → 20,200p
Current: 12,050p
Upside: +67.63%
argenx SE
Jul 28, 2026
Maintained: Buy
Price Target: €877.00 → €986.00
Current: €881.20
Upside: +11.89%
Roche Holding AG
Jul 27, 2026
Maintained: Buy
Price Target: CHF 395.00 → CHF 434.50
Current: CHF 367.40
Upside: +18.26%
Lonza Group AG
Jul 24, 2026
Maintained: Buy
Price Target: n/a
Current: $579.20
Upside: -
Novartis AG
Jul 22, 2026
Rated: Hold
Price Target: CHF 125.00 → CHF 133.00
Current: CHF 127.12
Upside: +4.63%
Novartis AG
Mar 19, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $160.31
Upside: -
Feb 23, 2026
Maintained: Sell
Price Target: kr 1,015 → kr 1,400
Current: kr 2,152
Upside: -34.94%
Sep 8, 2025
Reiterated: Sell
Price Target: n/a
Current: $34.11
Upside: -
Aug 17, 2025
Maintained: Hold
Price Target: n/a
Current: $28.24
Upside: n/a
Mar 31, 2025
Downgraded: Hold
Price Target: €10.50 → €2.90
Current: €0.98
Upside: n/a
Dec 10, 2024
Maintained: Buy
Price Target: €22.00 → €21.50
Current: €10.08
Upside: n/a
Mar 11, 2024
Downgraded: Hold
Price Target: $85 → $51
Current: $67.61
Upside: n/a
Mar 11, 2024
Downgraded: Sell
Price Target: $104
Current: $152.20
Upside: n/a
Nov 17, 2023
Upgraded: Buy
Price Target: €45.80 → €71.00
Current: €40.93
Upside: n/a
Nov 17, 2023
Maintained: Buy
Price Target: €69.00 → €70.00
Current: €46.65
Upside: n/a
Feb 27, 2023
Upgraded: Buy
Price Target: n/a
Current: $58.20
Upside: n/a
Nov 8, 2022
Downgraded: Hold
Price Target: $172 → $140
Current: $265.97
Upside: n/a
Sep 3, 2019
Upgraded: Buy
Price Target: n/a
Current: $52.88
Upside: n/a
Nov 12, 2018
Maintained: Buy
Price Target: n/a
Current: $13.69
Upside: n/a
Feb 24, 2017
Downgraded: Hold
Price Target: n/a
Current: $23.84
Upside: n/a
Apr 7, 2016
Initiated Coverage: Hold
Price Target: $78
Current: $1,280.34
Upside: n/a